ArticleDiscover oncology2026

Efficacy and safety of octreotide versus somatostatin therapy after CRS + HIPEC in patients with peritoneal carcinomatosis.

Bing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.